ASBP
Aspire Biopharma Holdings, Inc.
There isn't enough reported data to score ASBP yet.
ASBP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Strong |
ASBP's balance sheet is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its revenue.
ASBP PE Valuation
ASBP has no meaningful PE right now: it lost money over the past year.
ASBP Forward outlook
There aren't enough analyst estimates for ASBP to show an outlook.
ASBP Earnings Per Share
ASBP Quarterly Revenue
ASBP's revenue has grown year over year for four quarters in a row: $63,104 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4244% | N/A |
| Q1 2026 | -5806% | N/A |
| Q4 2025 | -43404% | N/A |
| Q3 2025 | -59016% | N/A |
ASBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.1M | -$975.4K |
| Q1 2026 | -$3M | -$1.3M |
| Q4 2025 | -$927.8K | -220% |
| Q2 2025 | -$1.1M | -$548K |
| Q1 2025 | -$1.8M | +$508.5K |
| Q4 2024 | $772.1K | +$928.3K |
| Q2 2024 | -$592.3K | -$402.4K |
| Q1 2024 | -$2.3M | -$2.1M |
ASBP has burned cash in almost every quarter: −$7M over the past year, against −$3M the year before.
ASBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2415% | +997K shares |
| 1 year | +2447% | +997K shares |
ASBP has 1M diluted shares, up 2447% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q2 2024 | $13.8M |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $632,968 |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
ASBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.0x | Very low |
| Q3 2023 | -0.0x | Very low |
| Q2 2023 | -0.1x | Net Cash |
| Q1 2023 | -0.2x | Net Cash |
ASBP's net debt is less than a year of its operating earnings (EBITDA).
ASBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.4 | Oversold |
| Stochastic | 60.1 | Neutral |
ASBP's weekly RSI is 25 (oversold) and its Stochastic is 60 (neutral).
ASBP PE vs Healthcare Sector
ASBP has no meaningful PE right now: it lost money over the past year.
ASBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.45 | 0.6% below |
| 20 week MA | $7.92 | 6.1% above |
| 50 week MA | $30.4 | 72% below |
| 100 week MA | $1,485.1 | 99% below |
| 200 week MA | $7,335.9 | 100% below |
ASBP's trend is mixed: it's above one of its five weekly moving averages, and 100% below its 200-week average.
ASBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $12,000.0 | $12,372.0 | +3.1% |
| 2023 | $12,372.0 | $13,068.0 | +5.6% |
| 2024 | $13,068.0 | $13,800.0 | +5.6% |
| 2025 | $13,800.0 | $129.6 | -99% |
| 2026 YTD | $129.6 | $8.40 | -94% |
ASBP is down 94% so far in 2026, after finishing higher in three of the previous four years.